Medtronic buys sinus-implant company for over $1 billion
August 06, 2021 at 12:03 PM EDT
Intersect ENT (NASDAQ: XENT) makes implants that open sinus passageways and deliver an anti-inflammatory steroid to help patients who suffer from chronic rhinosinusitits (CRS).
